REQUEST A DEMO
Total
USD $0.00
Search more companies

Novanta Ceska Republika S.R.O. (Czech Republic)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Novanta Ceska Republika S.R.O. Profile Updated: November 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Novanta Ceska Republika S.R.O. is an enterprise based in Czech Republic. Its main office is in Brno. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The enterprise was incorporated on March 02, 2016. 100 - 199 (2024) employees currently work for Novanta Ceska Republika S.R.O.. The latest financial highlights indicate a net sales revenue increase of 44.77% in 2022. Its’ total assets recorded a growth of 53.34%. Novanta Ceska Republika S.R.O.’s net profit margin decreased by 0.02% in 2022.

Headquarters
Palachovo namesti 726/3
Brno; Jihomoravsky; Postal Code: 62500

Contact Details: Purchase the Novanta Ceska Republika S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Novanta Ceska Republika S.R.O. report to view the information.
Outstanding Shares:
Purchase the Novanta Ceska Republika S.R.O. report to view the information.
Registered Capital:
Purchase the Novanta Ceska Republika S.R.O. report to view the information.
Incorporation Date:
March 02, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novanta Ceska Republika S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
44.77%
Total operating revenue
44.77%
Operating profit (EBIT)
44.66%
EBITDA
32.35%
Net Profit (Loss) for the Period
44.24%
Total assets
53.34%
Total equity
26.76%
Operating Profit Margin (ROS)
0%
Net Profit Margin
-0.02%
Return on Equity (ROE)
2.56%
Quick Ratio
-0.49%
Cash Ratio
-0.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?